Fusion Pharma: Astrazeneca swallows up Fusion Pharmaceuticals in 1.5bn move
Astrazeneca has completed its $2bn (£1.5bn) acquisition of Canada-based Fusion Pharmaceuticals, in a deal first announced in March.
Read full article »
Fusion Pharma is a Canada-based biopharmaceutical company that researches and develops radiation therapies for the treatment of cancer.
Read more